• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Senores Pharmaceuticals Limited — Updates, 20-01-2026: General Updates

    20-01-2026 | 02:08 pm

    Senores Pharma reported robust Q3FY26 results: Income Rs. 175 Cr (+64%), PAT Rs. 34 Cr (+105%). Apnar Pharma integration is faster, with 3 ANDAs launching Q4FY26. Emerging Markets saw highest-ever revenue & EBITDA, now cash flow positive. Branded Generics revenue grew 6x.

    No comments yet. Be the first to comment!

    All announcements from Senores Pharmaceuticals Limited